Phase 1: Potentiation of the Effect of Taxotere (Docetaxel) in Breast Cancer, Lung and Prostate Cancer Metastasis by Polyphenols From Food

Trial Profile

Phase 1: Potentiation of the Effect of Taxotere (Docetaxel) in Breast Cancer, Lung and Prostate Cancer Metastasis by Polyphenols From Food

Completed
Phase of Trial: Phase I

Latest Information Update: 15 May 2009

At a glance

  • Drugs Docetaxel (Primary)
  • Indications Advanced breast cancer; Non-small cell lung cancer; Prostate cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 15 May 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top